PerkinElmer's Shares Rise on Strong Q1 Results | GenomeWeb
NEW YORK (GenomeWeb News) – Shares of PerkinElmer climbed just above 15 percent in afternoon trading on the New York Stock Exchange following its announcement after the close of the market yesterday of strong first-quarter results.
PerkinElmer’s shares climbed as high as 20 percent to $27.25 during the trading session before settling back to $26.18 in the afternoon.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.